The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.

What the five have in common are software products aimed at helping providers improve patient engagement by leveraging AI. The recognized companies also meet IDC’s criteria for having revenues below $100 million.

Former FDA Commissioner Scott Gottlieb expects a vaccine for the new coronavirus, COVID-19, will be seasonal, akin to a flu shot.

U.S. Army researchers are calling for the creation of a national emergency network that would coordinate select digital health technologies, including AI, in fighting COVID-19 now and other public health crises later.

Cerner is partnering with 252-bed American Hospital Dubai to open a medical AI research center in the United Arab Emirates.

CMS is increasing enforcement, including civil penalties, against nursing homes with persistent infection control violations for COVID-19. 

Healthcare AI companies of all sizes need patient data to design their products and make their fortunes. Big healthcare providers have the data and need the tech partners to help advance modern medicine.

The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.

Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Disease (NIAID) and White House public health advisor, is concerned that a potential vaccine to protect against the novel coronavirus, COVID-19, may not deliver long-term immunity.

Johns Hopkins radiologists have repurposed a deep learning algorithm designed to detect tuberculosis on chest x-rays to, instead, help identify COVID-19.